Litcius/Paper detail

Benefit–Risk Assessment of Psychotropic Drugs in Older Patients with Chronic Obstructive Pulmonary Disease

Abebaw Mengistu Yohannes, Jeff Wang Jin, Mark E. Kunik

2022Drugs & Aging10 citationsDOI

Topics & Concepts

MedicineAntipsychoticAnxietyPsychiatryAdverse effectDepression (economics)COPDSchizophrenia (object-oriented programming)Bipolar disorderPopulationIntensive care medicineInternal medicineLithium (medication)Environmental healthMacroeconomicsEconomicsChronic Obstructive Pulmonary Disease (COPD) ResearchMusic Therapy and HealthCardiac Health and Mental Health
Benefit–Risk Assessment of Psychotropic Drugs in Older Patients with Chronic Obstructive Pulmonary Disease | Litcius